Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 638 of 1,261

  1. US 9624238

    4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  2. US 9624228

    Inhibitors of ERK and methods of use

    Kura Oncology, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  3. US 9624211

    Anti-cancer compounds

    The Board of Regents of the University of Texas System · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  4. US 9624182

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  5. US 9624184

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  6. US 9624156

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  7. US 9623124

    Multimodal diagnostic technology for early stage cancer lesions

    Northwestern University · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  8. US 9623112

    Dually derivatized chitosan nanoparticles and methods of making and using the same

    ENGENE, INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  9. US 9623103

    Arterivirus protein and expression mechanisms

    SOUTH DAKOTA BOARD OF REGENTS · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  10. US 9624152

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  11. US 9623097

    Yeast-brachyury immunotherapeutic compositions

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  12. US 9624229

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Rigel Pharmaceuticals, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  13. US 9623088

    Factor VIII polypeptide formulations

    BIOVERATIV THERAPEUTICS INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  14. US 9623085

    Chimeric natriuretic peptide compositions and methods of preparation

    Capricor Therapeutics, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  15. US 9623055

    Method for preventing and/or treating insulin resistance

    ACADEMISCH MEDISCH CENTRUM · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  16. US 9623051

    Decellularized extracellular matrix

    The Regents of the University of California · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  17. US 9623091

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  18. US 9624268

    Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

    Protagonist Therapeutics, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  19. US 9622991

    Hematopoietic growth factor mimetic small molecule compounds and their uses

    Ligand Pharmaceuticals Incorporated · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  20. US 9624304

    Antibodies which bind to epithelial membrane protein 2 (EMP2)

    The Regents of the University of California · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  21. US 9624306

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  22. US 9623151

    Biomaterials and implants for enhanced cartilage formation, and methods for making and using them

    The Regents of the University of California · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  23. US 9624498

    Methods and compositions for regulation of zinc finger protein expression

    Sangamo Biosciences, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  24. US 9623040

    Immunomodulation by controlling expression levels of microRNAs in dendritic cells

    The Regents of the University of California · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.